Markus Borner
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies 40
- Cancer Treatment and Pharmacology 31
- Cancer-related Molecular Pathways 13
- Pancreatic and Hepatic Oncology Research 11
-
- Gastric Cancer Management and Outcomes 18
- Lung Cancer Treatments and Mutations 12
- Cancer Research top 2%
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis 14
-
- Cell death mechanisms and regulation 8
- Co-authors
- Daniel BetticherFarzaneh PirniaАндреас КаппелерPiercarlo SalettiJim HeighwaySilvia VonlanthenMathias GuggerE Schneider
- Journals
- Annals of Oncology (20 papers)Journal of Clinical Oncology (19 papers)European Journal of Cancer (13 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Markus Borner
125 papers receiving 5.4k citations
Peers
Comparison fields: 5 of 135
- Oncology 3.0k
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 847
- Hepatology 425
- Pathology and Forensic Medicine 541
Countries citing papers authored by Markus Borner
This map shows the geographic impact of Markus Borner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Borner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Borner more than expected).
Fields of papers citing papers by Markus Borner
This network shows the impact of papers produced by Markus Borner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Borner. The network helps show where Markus Borner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Borner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 3 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 21 | |
| 4 | 2021 | 120 | |
| 5 | 2017 | 10 | |
| 6 | 2015 | 92 | |
| 7 | A multicentre inter-observer study on tumour budding using a 10HPF method in colorectal cancer: a study from the Swiss Association of Gastrointestinal Pathology (SAGIP) | 2014 | 2 |
| 8 | 2014 | 37 | |
| 9 | 2009 | 26 | |
| 10 | 2008 | 32 | |
| 11 | 2008 | 5 | |
| 12 | 2005 | 3 | |
| 13 | 2003 | 222 | |
| 14 | 2002 | 80 | |
| 15 | 2001 | 8 | |
| 16 | 2001 | 245 | |
| 17 | 2001 | 28 | |
| 18 | 1999 | 1 | |
| 19 | 1998 | 45 | |
| 20 | 1997 | 5 |
About Markus Borner
Markus Borner is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 126 papers that have together received 5.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (40 papers), Cancer Treatment and Pharmacology (31 papers), Gastric Cancer Management and Outcomes (18 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer-related Molecular Pathways (13 papers), Lung Cancer Treatments and Mutations (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cell death mechanisms and regulation (8 papers). The work is most often cited by research in Oncology (3.0k citations), Pulmonary and Respiratory Medicine (1.8k citations) and Cancer Research (847 citations). Markus Borner has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Daniel Betticher, Farzaneh Pirnia, Андреас Каппелер, Piercarlo Saletti, Jim Heighway, Silvia Vonlanthen, Mathias Gugger, E Schneider, A. Roth and Richard Herrmann. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.